Sophie Titoulet Announces Challenge Plasma 2026: The Art of Giving Regularly
Sophie Titoulet, Director of Communications and Marketing at the French Blood Establishment, shared on LinkedIn:
”First plasma donation of the 2026 winter season at Maison de Lyon Confluence Perrache!
Donating with family or colleagues is a great opportunity to spend some quality time together…
Thank you, Francois Bruno, for your generous gesture!
The Art of Giving Regularly
With the patron of our challenge, artist Monsieur Lemdi, and the teams at the EFS blood center in the Auvergne Rhône Alpes region, let’s take up the challenge of “the art of giving regularly” with one donation per season!
Generosity, Enthusiasm, and the Beauty of the Gesture to provide long-term support to patients treated with blood, plasma, and platelet donations…
Plasma is used to manufacture treatments that are essential for thousands of people: immunodeficiencies, autoimmune diseases, hemophilia…
When is your next donation?
Link to make an appointment.
Challenge Plasma 2026: At least one donation per season
Cathy Bliem, Cyril Robin, Patricia Chavarin, Caroline Alizard, Céline Aubonnet, Fabrice Cognasse, Maxime Guilloux: next time, let’s make our appointments together!”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day